Model Number 8637-40 |
Device Problem
Adverse Event Without Identified Device or Use Problem (2993)
|
Patient Problems
Muscle Weakness (1967); Sedation (2368); Loss of consciousness (2418); Lethargy (2560)
|
Event Date 10/19/2018 |
Event Type
Injury
|
Manufacturer Narrative
|
If information is provided in the future, a supplemental report will be issued.
|
|
Event Description
|
Information was received from a healthcare provider via a company representative regarding a patient receiving gablofen 2000mcg/ml at 150mcg/day via an implantable pump.The indication for use was intractable spasticity.On (b)(6) 2019 it was reported that since the patient¿s first refill, the patient has been having episodes.The reporter stated that one refill they increased the medication from 130mcg/day to 150mcg/day and the same lot of medication had been in there since.Per the reporter, the patient¿s mother reported the patient has been having episode about every 10 days where she is sedated and unresponsive.The mom says these episodes last between a couple of hours to a couple of days and nothing seems to make it better, the patient eventually just comes out of it.They performed a dye study today and everything was normal, they looked at the rollers during the dye study and saw the rollers move 90 degrees.No further complications were reported or anticipated.
|
|
Manufacturer Narrative
|
If information is provided in the future, a supplemental report will be issued.
|
|
Event Description
|
On 2019-mar-22, additional information was received from the healthcare professional (hcp).The hcp reported the cause of the symptoms has not been determined.The dose has been decreased from 150 mcg/day to 120 mcg/day.The pump was refilled early to asses actual volume compared to estimated volume.The pump was filled with 20 ml given the low daily dose.The next refill was scheduled for (b)(6) 2019.
|
|
Manufacturer Narrative
|
If information is provided in the future, a supplemental report will be issued.
|
|
Event Description
|
On 2019-may-28, additional information was received from the healthcare professional (hcp).The hcp reported the cause of the patient's symptoms has not been determined.The hcp reported further actions taken; management coordinated with neurology: monitor for resolution of symptoms of hypotonia with itb pump at minimal rate and oral baclofen.Differential diagnosis includes autonomic failure per neurology.
|
|
Manufacturer Narrative
|
If information is provided in the future, a supplemental report will be issued.
|
|
Event Description
|
On 2019-may-03, additional information was received from the healthcare professional (hcp).Additional information reported the refill was moved up to (b)(6) 2019 because the patient had a very long episode of lethargy and loss of tone following the dye and roller study on (b)(6) 2019.Upon interrogation of the patient's pump, estimated residual volume was 28.8 ml and logs showed no alarms or motor stalls.During the refill, approximately 29 ml of baclofen was aspirated.Patient's dose was decreased from 150 mcg/day to 120 mcg/day and she was refilled with 20 ml (not 40 ml).Of note, patient was monitored in the hospital with continuous eeg and an episode of lethargy/hypotonia was captured.Subsequently, pump rate was turned down to minimum rate; she has supplemental enteral baclofen.
|
|
Search Alerts/Recalls
|